|
|
|
|
|
1.
|
Breast cancer risk-assessment models
D Gareth R Evans, Anthony Howell Breast Cancer Research 2007, 9:213 (12 September 2007)
Abstract | Full text | PDF | PubMed
|
|
|
2.
|
Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells
Bin Qin, Kun Cheng Breast Cancer Research 2010, 12:R74 (23 September 2010)
Abstract | Full text | PDF | PubMed
|
|
|
3.
|
Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
Rafat A Siddiqui, Mustapha Zerouga, Min Wu, Alicia Castillo, Kevin Harvey, Gary P Zaloga, William Stillwell Breast Cancer Research 2005, 7:R645-R654 (7 June 2005)
Abstract | Full text | PDF | PubMed |
|
Editor’s summary
Omega-3 fatty acids combined with propofol have potential as an anti-cancer drug by inhibiting cancer cell adhesion, reducing cell migration and inducing apoptosis.
|
|
|
4.
|
Mouse models of breast cancer metastasis
Anna Fantozzi, Gerhard Christofori Breast Cancer Research 2006, 8:212 (26 July 2006)
Abstract | Full text | PDF | PubMed
|
|
|
5.
|
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
Tatsuya Toyama, Zhenhuan Zhang, Mariko Nishio, Maho Hamaguchi, Naoto Kondo, Hirotaka Iwase, Hiroji Iwata, Satoru Takahashi, Hiroko Yamashita, Yoshitaka Fujii Breast Cancer Research 2007, 9:R34 (30 May 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
6.
|
P-cadherin expression in breast cancer: a review
Joana Paredes, Ana Correia, Ana Ribeiro, André Albergaria, Fernanda Milanezi, Fernando C Schmitt Breast Cancer Research 2007, 9:214 (31 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
7.
|
Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
RE Coleman Breast Cancer Research 2009, 11(Suppl 1):S16 (23 June 2009)
Full text | PDF
|
|
|
8.
|
The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition
Jianxun Han, Ivy Ma, Michael J Hendzel, Joan Allalunis-Turner Breast Cancer Research 2009, 11:R57 (6 August 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central | F1000 Biology
|
|
|
9.
|
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
Adalgeir Arason, Haukur Gunnarsson, Gudrun Johannesdottir, Kristjan Jonasson, Pär-Ola Bendahl, Elizabeth M Gillanders, Bjarni A Agnarsson, Göran Jönsson, Katri Pylkäs, Aki Mustonen, Tuomas Heikkinen, Kristiina Aittomäki, Carl Blomqvist, Beatrice Melin, Oskar TH Johannsson, Pål Møller, Robert Winqvist, Heli Nevanlinna, Åke Borg, Rosa B Barkardottir Breast Cancer Research 2010, 12:R50 (16 July 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
10.
|
Controversies in Breast Cancer 2010
William R Miller Breast Cancer Research 2010, 12(Suppl 4):S1 (20 December 2010)
Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
11.
|
Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
Kathleen I Pritchard Breast Cancer Research 2010, 12(Suppl 4):S18 (20 December 2010)
Full text | PDF | PubMed
|
|
|
12.
|
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
Ingunn Holen, Robert E Coleman Breast Cancer Research 2010, 12:214 (16 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
13.
|
Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
Ferdinando Mannello, Giancarlo Gazzanelli Breast Cancer Res 2001, 3:238-243 (10 May 2001)
Abstract | Full text | PDF | PubMed
|
|
|
14.
|
Molecular profiling of patient-derived breast cancer xenografts
Fabien Reyal, Charlotte Guyader, Charles Decraene, Carlo Lucchesi, Nathalie Auger, Franck Assayag, Ludmilla De Plater, David Gentien, Marie-France Poupon, Paul Cottu, Patricia De Cremoux, Pierre Gestraud, Anne Vincent-Salomon, Jean-Jacques Fontaine, Sergio Roman-Roman, Olivier Delattre, Didier Decaudin, Elisabetta Marangoni Breast Cancer Research 2012, 14:R11 (16 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
15.
|
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers
Desheng Weng, Jeffrey H Penzner, Baizheng Song, Shigeo Koido, Stuart K Calderwood, Jianlin Gong Breast Cancer Research 2012, 14:R18 (25 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
16.
|
The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation
Joseph P Garay, Bedri Karakas, Abde M Abukhdeir, David P Cosgrove, John P Gustin, Michaela J Higgins, Hiroyuki Konishi, Yuko Konishi, Josh Lauring, Morassa Mohseni, Grace M Wang, Danijela Jelovac, Ashani Weeraratna, Cheryl A Sherman Baust, Patrice J Morin, Antoun Toubaji, Alan Meeker, Angelo M De Marzo, Gloria Lewis, Andrea Subhawong, Pedram Argani, Ben H Park Breast Cancer Research 2012, 14:R27 (9 February 2012)
Abstract | Full text | PDF | PubMed
|
|
|
17.
|
Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term
Rachel C Jankowitz, Adam M Brufsky Breast Cancer Research 2012, 14:308 (30 April 2012)
Abstract | Full text | PDF | PubMed
|
|
|
18.
|
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Leonardo Salmena, Henry T Lynch, Charmaine Kim-Sing, William D Foulkes, Parviz Ghadirian, Susan L Neuhausen, Rochelle Demsky, Nadine Tung, Peter Ainsworth, Leigha Senter, Andrea Eisen, Charis Eng, Christian Singer, Ophira Ginsburg, Joanne Blum, Tomasz Huzarski, Aletta Poll, Ping Sun, Steven A Narod, the Hereditary Breast Cancer Clinical Study Group Breast Cancer Research 2012, 14:R42 (9 March 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Breastfeeding is protective against BRCA1- but not BRCA2-associated breast cancer, suggesting they have different biological pathways for carcinogenesis, and mutation carriers should be advised of the potential benefit of breastfeeding.
|
|
|
19.
|
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells
Laura Abalsamo, Francesca Spadaro, Giuseppina Bozzuto, Luisa Paris, Serena Cecchetti, Luana Lugini, Egidio Iorio, Agnese Molinari, Carlo Ramoni, Franca Podo Breast Cancer Research 2012, 14:R50 (19 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
20.
|
Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype
MJ Núñez-Villar, F Martínez-Arribas, M Pollán, AR Lucas, J Sánchez, A Tejerina, J Schneider Breast Cancer Res 2003, 5:R65-R70 (6 March 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
21.
|
The thyroid, iodine and breast cancer
Peter PA Smyth Breast Cancer Res 2003, 5:235-238 (29 July 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
22.
|
Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
Hiroko Yamashita, Mariko Nishio, Tatsuya Toyama, Hiroshi Sugiura, Zhenhuan Zhang, Shunzo Kobayashi, Hirotaka Iwase Breast Cancer Res 2004, 6:R24-R30 (7 November 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
23.
|
The changing global patterns of female breast cancer incidence and mortality
Freddie Bray, Peter McCarron, D Maxwell Parkin Breast Cancer Res 2004, 6:229-239 (26 August 2004)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|